Lexington Biosciences, Inc. appointed Mr. Eric Willis as company President, and Mr. Doug Janzen as Board Chairman. Mr. Willis is a twenty plus year experience in the healthcare technology industry with a passion for working closely with clinicians to bring products from concept to market. Previously he was the President and CEO of InSite Medical Technologies.

He was also the President of ParaPatch, the General Manager of Atia Medical, and previously served as Director of New Therapies for Guidant Cardiac Surgery, as well as having held a variety of core product development roles for Foxhollow, Heartport; and DVI/Guidant. Mr. Janzen brings over 20 years of experience in life sciences with leadership experience in corporate finance, business development, and operational management of life sciences companies. He is currently Co-Founder and Managing Director of Northview Ventures.

He serves as Chairman and CEO of Aequus Pharmaceuticals (founded within Northview).